Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings

Mountain Valley MD Announces Closing of Non-Brokered Private Placement of Units and Concurrent Shares for Debt Transactions

MVMD Closes Financing to Fuel Agrarius Commercialization Amid Dilutive Share Issuance

By The Northwire Desk — AI Analysis Apr 15, 2026 · 08:00 MVMD · 0.05 Mountain Valley MD Holdings Inc.
Executive Summary
  • Mountain Valley MD Holdings Inc. (MVMD) announced the closing of a non-brokered private placement on April 15, 2026.
  • The company raised CAD $2,000,000 in gross proceeds by issuing 80,000,000 units at CDN $0.025 per unit.
  • Each unit consists of one common share and one common share purchase warrant exercisable at CDN $0.08 for 12 months.
  • Concurrently, MVMD settled CAD $485,000 in outstanding debt through "shares for debt" transactions (22,647,058 shares at $0.017 and 2,000,000 shares at $0.05).
  • The financing was previously announced on March 31, 2026, with closing expected in April 2026.
  • Proceeds are designated for general working capital purposes to support ongoing operations.
  • Securities are subject to a four-month and one-day hold period expiring August 15, 2026.
Material Impact
  • The financing confirms the execution of the March 31 announcement; therefore, it contains no new unexpected information regarding terms or amounts.
  • Raising CAD $2 million provides immediate liquidity to fund commercialization efforts highlighted in December 2025 updates (Agrarius trials).
  • Debt settlement via equity issuance reduces balance sheet liabilities but increases share count dilution significantly.
  • The unit price of $0.025 is extremely low, indicating the company's valuation remains at penny stock levels despite positive operational data from Brazil citrus trials (+49% yield increase).
  • Warrant acceleration clause (triggered if CSE VWAP >= $0.12 for 10 days) creates a potential future dilution event if the stock rallies significantly above current levels.
  • The transaction is categorized as Routine - Positive because it was fully disclosed in advance and represents standard capital raising behavior for early-stage biotech/agri-tech firms.
MVMD · Price
Company Overview
  • Mountain Valley MD Holdings Inc. operates across three core platforms: Quicksome (nutraceuticals), Agrarius (agricultural signaling), and Soluvec (animal husbandry/aquatic).
  • Flagship Project: Agrarius, a plant-signaling additive showing significant yield improvements in Brazil citrus trials (+15% to +49%).
  • Quicksome holds exclusive manufacturing/licensing with Circadian Wellness for sublingual products ("Eons Dialed", "Eons Deeper Sleep").
  • Soluvec is an ivermectin formulation licensed in Bangladesh, though revenue has been impacted by market disruptions.
  • Company focuses on low-capital, royalty-based arrangements to expand asset portfolio without heavy operational overhead.
Read the original news release →

More from Mountain Valley MD Holdings Inc.

May 29, 2026 · 08:30

MVMD Advances Peptide Platform Ahead of July FDA Catalyst, Balance Sheet Fortified by Recent Financing

Production / Operations Mar 31, 2026 · 18:23

Mountain Valley arranges offering, two debt settlements

Financings Mar 31, 2026 · 08:30

MVMD Secures $2M Lifeline at Steep Discount as Warrant Strike Aligns with Recent Price Spike

Financings Dec 24, 2025 · 17:55

Mountain Valley MD Provides Year-End Business Update, Advances Commercialization Across Core Platforms

Production / Operations Dec 01, 2025 · 17:45

Mountain Valley MD Confirms Positive Agrarius Agricultural Trial Results, Advancing Toward Commercialization

Production / Operations